MFM consult: Electronic fetal monitoring guidelines

Article

The new classification system provides three categories of risk: FHR tracings normal, indeterminate, and abnormal. The Society for Maternal Fetal Medicine provides insights on how to use these guidelines.

Why was a new NICHD workshop on electronic fetal monitoring reconvened?

In the 1990s, the National Institute of Child Health and Human Development (NICHD) sponsored a series of workshops that culminated in the publication of nomenclature, definitions, and guidelines for electronic fetal heart rate monitoring (EFM) in 1997.1 Since then, a number of organizations have produced new documents on EFM that have included different pattern interpretation systems.2 In 2008, the American College of Obstetricians and Gynecologists (ACOG), the Eunice Kennedy Shriver National Institute of Child Health and Human Development, and the Society for Maternal-Fetal Medicine co-sponsored a follow-up workshop on EFM with the following goals: (1) review and update the definitions for fetal heart rate (FHR) patterns from the prior workshop, (2) evaluate existing classification systems and make a recommendation for a system for use in the United States, and (3) set research priorities for EFM.3 Our hope was that a revised classification system would allow for clearer communication between all members of the health-care team.

How was the new classification system selected?

The NICHD group was most interested in a simple system that would improve communication among clinicians. With that in mind, we decided on a three-tier system for categorization (Table 1). Naming the categories was a surprisingly difficult task, but ultimately we settled on three simple categories:

We did recognize that many EFM tracings are Category II and that tracings can change back and forth between categories over time.

How have definitions and nomenclature changed?

The new definitions are similar to the older ones in many respects. We reaffirmed the previous definitions for baseline FHR, FHR variability, accelerations, and decelerations. It's important to stress that there is no distinction between long-term and short-term variability-variability should be assessed as a single unit.

One difference is in the nomenclature for uterine contractions. In the past, many terms were used for frequent contractions, including tachysystole, hyperstimulation, hypertonus, and hypercontractility. That was confusing and fostered miscommunication. The guideline recommended new nomenclature for uterine contractions as follows.

Contractions are quantified as the number present in a 10-minute window, but averaged over 30 minutes.

NORMAL: Five or fewer contractions in 10 minutes, averaged over 30 minutes.

TACHYSYSTOLE: More than five contractions in 10 minutes, averaged over 30 minutes.

Tachysystole should be further qualified as to the presence or absence of associated FHR decelerations. With this new system, terms like hyperstimulation and hypercontractility should be abandoned.

Recent Videos
JoAnn Pinkerton discusses elinzanetant's crucial role in VMS therapy | Image Credit: uvahealth.com
Empowering women to take charge of their health | Image Credit: © piecesofi.com - © piecesofi.com - stock.adobe.com.
Supporting women through menopause with knowledge and care | Image Credit: © SHOTPRIME STUDIO - © SHOTPRIME STUDIO - stock.adobe.com.
How fezolinetant revolutionizes non-hormonal menopause therapy | Image Credit: imsociety.org
Gulf War exposures linked to early menopause in women veterans | Image Credit: linkedin.com.
Vanessa Muñiz discusses benefits of clinical hypnosis against hot flashes | Image Credit: mindbodymedicine.artsandsciences.baylor.edu
Elinzanetant displays positive phase 3 safety and efficacy data against VMS | Image Credit: © toeytoey - © toeytoey - stock.adobe.com.
© 2024 MJH Life Sciences

All rights reserved.